Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit


Chat with the Seattle Genetics Team

Tom Liptak, R.Ph

Registered Pharmacist
Senior Oncology Account Manager, Sales-Northeast Region
T: 412-607-0250      C: 412-607-0250             

Mary Jo Capozzoli, RN, BSN

Senior Oncology Account Manager, Seagen


Jim Turconi

Senior Oncology Account Manager, Seagen





                            PADCEV HCP Homepage

                            PADCEV (enfortumab vedotin-ejfv) Prescribing Information


                            ADCETRIS HCP Website 

                            ADCETRIS 5-Year ECHELON-1 Update

                            Request a Rep to Learn More About ADCETRIS

                            ADCETRIS Core Visual Aid


                           TUKYSA (tucatinib) tablets Prescribing Information

                            TUKYSA HCP Website

                            Request a Rep to Learn More About TUKYSA

                            TUKYSA Dosing and Administration Guide

                            Medical Affairs Scientific Engagement Experience

                            Submit A Medical Information Request


Back to the Virtual Exhibit Hall